Chemomab Therapeutics Ltd DRC Cash Flow Quality Index
Chemomab Therapeutics Ltd DRC cash flow quality index. Chemomab Therapeutics Ltd DRC (CMMB) has a Cash Flow Quality Index of -0.69x as of December 2019. Operating cash flow of $-6.26 Million is below net income of $9.08 Million, suggesting accrual-heavy earnings not yet converted to cash. See CMMB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chemomab Therapeutics Ltd DRC Cash Flow Quality Index by Year (None–None)
Chemomab Therapeutics Ltd DRC cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Chemomab Therapeutics Ltd DRC. For the full cash flow conversion analysis, see cash flow conversion of Chemomab Therapeutics Ltd DRC.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|